Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

1 week ago 10
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

Related

China considers exempting some US goods from 125% tariffs- Bloomberg

China considers exempting some US goods from 125% tariffs- B...

2 hours ago 0
China considers exempting some goods from US tariffs, source says

China considers exempting some goods from US tariffs, source...

2 hours ago 0
Morning Bid: Focus on earnings while US and China quibble

Morning Bid: Focus on earnings while US and China quibble

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. mark daigneault
2. tuomas iisalo
3. kenley jansen
4. power
5. nba scores today
6. jaren jackson jr.
7. ben simmons
8. kris dunn
9. ivica zubac
10. diamondbacks

Popular

Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

1 week ago 73
What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

1 week ago 70
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

1 week ago 64
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

1 week ago 62
Trump praises Whitmer in friendly Oval Office meeting

Trump praises Whitmer in friendly Oval Office meeting

2 weeks ago 59
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved